Do analysts recommend MYNZ or SYPR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Sypris Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer MYNZ or XTIA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 XTI Aerospace 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media prefer MYNZ or XTIA?

In the previous week, XTI Aerospace had 16 more articles in the media than Mainz Biomed. MarketBeat recorded 17 mentions for XTI Aerospace and 1 mentions for Mainz Biomed. XTI Aerospace's average media sentiment score of 0.07 beat Mainz Biomed's score of -0.71 indicating that XTI Aerospace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mainz Biomed 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative XTI Aerospace 0 Very Positive mention(s) 0 Positive mention(s) 16 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer MYNZ or VTSI?

VirTra has a consensus price target of $5.00, suggesting a potential upside of 72.41%. Given VirTra's stronger consensus rating and higher probable upside, analysts plainly believe VirTra is more favorable than Mainz Biomed. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 VirTra 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better valuation and earnings, MYNZ or VTSI?

VirTra has higher revenue and earnings than Mainz Biomed. VirTra is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mainz Biomed $659.94K 18.12 -$21.65M -$65.60 N/A VirTra $22.40M 1.47 $260K -$0.26 N/A

Do analysts rate MYNZ or ZENA?

ZenaTech has a consensus price target of $4.50, indicating a potential upside of 208.22%. Given ZenaTech's stronger consensus rating and higher probable upside, analysts plainly believe ZenaTech is more favorable than Mainz Biomed. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 ZenaTech 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has higher earnings and valuation, MYNZ or ZENA?

Mainz Biomed has higher earnings, but lower revenue than ZenaTech. ZenaTech is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mainz Biomed $659.94K 18.12 -$21.65M -$65.60 N/A ZenaTech $20.18M 1.63 -$32.36M -$1.42 N/A

Is MYNZ or ZENA more profitable?

Mainz Biomed has a net margin of 0.00% compared to ZenaTech's net margin of -332.51%. Company Net Margins Return on Equity Return on Assets Mainz Biomed N/A N/A N/A ZenaTech -332.51% N/A -78.90%

Does the media refer more to MYNZ or ZENA?

In the previous week, ZenaTech had 8 more articles in the media than Mainz Biomed. MarketBeat recorded 9 mentions for ZenaTech and 1 mentions for Mainz Biomed. ZenaTech's average media sentiment score of 0.81 beat Mainz Biomed's score of -0.71 indicating that ZenaTech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mainz Biomed 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative ZenaTech 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate MYNZ or EURK?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Eureka Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, MYNZ or EURK?

Eureka Acquisition has lower revenue, but higher earnings than Mainz Biomed. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mainz Biomed $659.94K 18.12 -$21.65M -$65.60 N/A Eureka Acquisition N/A N/A N/A N/A N/A

Is MYNZ or EURK more profitable?

Company Net Margins Return on Equity Return on Assets Mainz Biomed N/A N/A N/A Eureka Acquisition N/A N/A N/A

Mainz Biomed (MYNZ) Competitors

$1.32 0.00 (0.00%)

As of 09/23/2026

Compare

MYNZ vs. SYPR, XTIA, VTSI, ZENA, and EURK

Should you buy Mainz Biomed stock or one of its competitors? Mainz Biomed's main competitors and comparable companies include Sypris Solutions (SYPR), XTI Aerospace (XTIA), VirTra (VTSI), ZenaTech (ZENA), and Eureka Acquisition (EURK). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "aerospace & defense" industry.

How does Mainz Biomed compare to Sypris Solutions?

Mainz Biomed (NASDAQ:MYNZ) and Sypris Solutions (NASDAQ:SYPR) are both small-cap industrials companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

Mainz Biomed has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market. Comparatively, Sypris Solutions has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market.

44.7% of Sypris Solutions shares are held by institutional investors. 18.2% of Mainz Biomed shares are held by insiders. Comparatively, 47.9% of Sypris Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Sypris Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Mainz Biomed and Mainz Biomed both had 1 articles in the media. Sypris Solutions' average media sentiment score of 1.84 beat Mainz Biomed's score of -0.71 indicating that Sypris Solutions is being referred to more favorably in the news media.

Company	Overall Sentiment
Mainz Biomed	Negative
Sypris Solutions	Very Positive

Sypris Solutions has higher revenue and earnings than Mainz Biomed. Sypris Solutions is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$659.94K	18.12	-$21.65M	-$65.60	N/A
Sypris Solutions	$119.89M	0.34	-$6.34M	-$0.47	N/A

Mainz Biomed has a net margin of 0.00% compared to Sypris Solutions' net margin of -9.23%. Mainz Biomed's return on equity of 0.00% beat Sypris Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
Sypris Solutions	-9.23%	-67.14%	-9.87%

Summary

Sypris Solutions beats Mainz Biomed on 7 of the 13 factors compared between the two stocks.

How does Mainz Biomed compare to XTI Aerospace?

Mainz Biomed (NASDAQ:MYNZ) and XTI Aerospace (NASDAQ:XTIA) are both small-cap industrials companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

Mainz Biomed has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, XTI Aerospace has a beta of 4.79, meaning that its share price is 379% more volatile than the broader market.

In the previous week, XTI Aerospace had 16 more articles in the media than Mainz Biomed. MarketBeat recorded 17 mentions for XTI Aerospace and 1 mentions for Mainz Biomed. XTI Aerospace's average media sentiment score of 0.07 beat Mainz Biomed's score of -0.71 indicating that XTI Aerospace is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mainz Biomed	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
XTI Aerospace	0 Very Positive mention(s)	0 Positive mention(s)	16 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Mainz Biomed has higher earnings, but lower revenue than XTI Aerospace. XTI Aerospace is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$659.94K	18.12	-$21.65M	-$65.60	N/A
XTI Aerospace	$22.49M	1.64	-$68.76M	-$5.20	N/A

Mainz Biomed has a net margin of 0.00% compared to XTI Aerospace's net margin of -171.13%. Mainz Biomed's return on equity of 0.00% beat XTI Aerospace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
XTI Aerospace	-171.13%	-2,044.78%	-105.02%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
XTI Aerospace	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

11.7% of XTI Aerospace shares are owned by institutional investors. 18.2% of Mainz Biomed shares are owned by company insiders. Comparatively, 7.4% of XTI Aerospace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

XTI Aerospace beats Mainz Biomed on 8 of the 15 factors compared between the two stocks.

How does Mainz Biomed compare to VirTra?

Mainz Biomed (NASDAQ:MYNZ) and VirTra (NASDAQ:VTSI) are both small-cap industrials companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Mainz Biomed has a net margin of 0.00% compared to VirTra's net margin of -17.04%. Mainz Biomed's return on equity of 0.00% beat VirTra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
VirTra	-17.04%	-6.59%	-4.57%

VirTra has a consensus price target of $5.00, suggesting a potential upside of 72.41%. Given VirTra's stronger consensus rating and higher probable upside, analysts plainly believe VirTra is more favorable than Mainz Biomed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
VirTra	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

14.7% of VirTra shares are held by institutional investors. 18.2% of Mainz Biomed shares are held by insiders. Comparatively, 3.5% of VirTra shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Mainz Biomed has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market. Comparatively, VirTra has a beta of 0.71, meaning that its stock price is 29% less volatile than the broader market.

In the previous week, Mainz Biomed and Mainz Biomed both had 1 articles in the media. VirTra's average media sentiment score of 0.34 beat Mainz Biomed's score of -0.71 indicating that VirTra is being referred to more favorably in the news media.

Company	Overall Sentiment
Mainz Biomed	Negative
VirTra	Neutral

VirTra has higher revenue and earnings than Mainz Biomed. VirTra is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$659.94K	18.12	-$21.65M	-$65.60	N/A
VirTra	$22.40M	1.47	$260K	-$0.26	N/A

Summary

VirTra beats Mainz Biomed on 9 of the 15 factors compared between the two stocks.

How does Mainz Biomed compare to ZenaTech?

Mainz Biomed (NASDAQ:MYNZ) and ZenaTech (NASDAQ:ZENA) are both small-cap industrials companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.

Mainz Biomed has a net margin of 0.00% compared to ZenaTech's net margin of -332.51%.

Company	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
ZenaTech	-332.51%	N/A	-78.90%

Mainz Biomed has higher earnings, but lower revenue than ZenaTech. ZenaTech is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$659.94K	18.12	-$21.65M	-$65.60	N/A
ZenaTech	$20.18M	1.63	-$32.36M	-$1.42	N/A

Mainz Biomed has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, ZenaTech has a beta of 7.21, meaning that its share price is 621% more volatile than the broader market.

ZenaTech has a consensus price target of $4.50, indicating a potential upside of 208.22%. Given ZenaTech's stronger consensus rating and higher probable upside, analysts plainly believe ZenaTech is more favorable than Mainz Biomed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
ZenaTech	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, ZenaTech had 8 more articles in the media than Mainz Biomed. MarketBeat recorded 9 mentions for ZenaTech and 1 mentions for Mainz Biomed. ZenaTech's average media sentiment score of 0.81 beat Mainz Biomed's score of -0.71 indicating that ZenaTech is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mainz Biomed	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
ZenaTech	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

ZenaTech beats Mainz Biomed on 8 of the 13 factors compared between the two stocks.

How does Mainz Biomed compare to Eureka Acquisition?

Mainz Biomed (NASDAQ:MYNZ) and Eureka Acquisition (NASDAQ:EURK) are both small-cap industrials companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

In the previous week, Eureka Acquisition had 1 more articles in the media than Mainz Biomed. MarketBeat recorded 2 mentions for Eureka Acquisition and 1 mentions for Mainz Biomed. Eureka Acquisition's average media sentiment score of 1.39 beat Mainz Biomed's score of -0.71 indicating that Eureka Acquisition is being referred to more favorably in the news media.

Company	Overall Sentiment
Mainz Biomed	Negative
Eureka Acquisition	Positive

Mainz Biomed has a beta of 0.31, indicating that its stock price is 69% less volatile than the broader market. Comparatively, Eureka Acquisition has a beta of -0.07, indicating that its stock price is 107% less volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
Eureka Acquisition	N/A	N/A	N/A

Eureka Acquisition has lower revenue, but higher earnings than Mainz Biomed.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$659.94K	18.12	-$21.65M	-$65.60	N/A
Eureka Acquisition	N/A	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Eureka Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Mainz Biomed beats Eureka Acquisition on 3 of the 5 factors compared between the two stocks.

Get Mainz Biomed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MYNZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MYNZ vs. The Competition

Export

Metric	Mainz Biomed	Aerospace & Defense Industry	Industrials Sector	NASDAQ Exchange
Market Cap	$11.96M	$20.63B	$10.34B	$13.29B
Dividend Yield	N/A	1.68%	96.94%	12.57%
P/E Ratio	-0.02	37.57	25.25	25.76
Price / Sales	18.12	144.38	289.26	106.88
Price / Cash	N/A	26.28	24.10	52.76
Price / Book	0.51	7.40	4.82	6.34
Net Income	-$21.65M	$567.30M	$613.71M	$360.00M
7 Day Performance	-2.94%	0.16%	0.45%	-0.18%
1 Month Performance	0.76%	-6.84%	-2.93%	-4.09%
1 Year Performance	-14.84%	1.99%	4.47%	5.97%

Mainz Biomed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MYNZ Mainz Biomed	0.3151 of 5 stars	$1.32 flat	N/A	-18.0%	$11.96M	$659.94K	N/A	30
SYPR Sypris Solutions	0.7344 of 5 stars	$1.74 -4.9%	N/A	-21.0%	$40.07M	$119.89M	N/A	680	Positive News
XTIA XTI Aerospace	0.9755 of 5 stars	$0.96 -6.1%	N/A	-39.3%	$36.87M	$50.19M	N/A	12
VTSI VirTra	3.6141 of 5 stars	$2.90 -1.0%	$5.00 +72.4%	-47.2%	$32.83M	$22.40M	N/A	120	Gap Up
ZENA ZenaTech	2.5474 of 5 stars	$1.41 -4.7%	$4.50 +219.1%	-71.7%	$31.73M	$9.24M	N/A	11	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MYNZ) was last updated on 9/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mainz Biomed (MYNZ) Competitors

MYNZ vs. SYPR, XTIA, VTSI, ZENA, and EURK

How does Mainz Biomed compare to Sypris Solutions?

Summary

How does Mainz Biomed compare to XTI Aerospace?

Summary

How does Mainz Biomed compare to VirTra?

Summary

How does Mainz Biomed compare to ZenaTech?

Summary

How does Mainz Biomed compare to Eureka Acquisition?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MYNZ vs. The Competition

Mainz Biomed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mainz Biomed (MYNZ) Competitors

MYNZ vs. SYPR, XTIA, VTSI, ZENA, and EURK

How does Mainz Biomed compare to Sypris Solutions?

Which has more risk and volatility, MYNZ or SYPR?

Do insiders and institutionals hold more shares of MYNZ or SYPR?

Do analysts recommend MYNZ or SYPR?

Does the media prefer MYNZ or SYPR?

Which has preferable valuation and earnings, MYNZ or SYPR?

Is MYNZ or SYPR more profitable?

Summary

How does Mainz Biomed compare to XTI Aerospace?

Which has more volatility & risk, MYNZ or XTIA?

Does the media prefer MYNZ or XTIA?

Which has stronger earnings and valuation, MYNZ or XTIA?

Is MYNZ or XTIA more profitable?

Do analysts prefer MYNZ or XTIA?

Do insiders & institutionals hold more shares of MYNZ or XTIA?

Summary

How does Mainz Biomed compare to VirTra?

Is MYNZ or VTSI more profitable?

Do analysts prefer MYNZ or VTSI?

Do institutionals and insiders hold more shares of MYNZ or VTSI?

Which has more risk and volatility, MYNZ or VTSI?

Does the media prefer MYNZ or VTSI?

Which has better valuation and earnings, MYNZ or VTSI?

Summary

How does Mainz Biomed compare to ZenaTech?

Is MYNZ or ZENA more profitable?

Which has higher earnings and valuation, MYNZ or ZENA?

Which has more risk & volatility, MYNZ or ZENA?

Do analysts rate MYNZ or ZENA?

Does the media refer more to MYNZ or ZENA?

Summary

How does Mainz Biomed compare to Eureka Acquisition?

Does the media favor MYNZ or EURK?

Which has more volatility and risk, MYNZ or EURK?

Is MYNZ or EURK more profitable?

Which has preferable earnings & valuation, MYNZ or EURK?

Do analysts rate MYNZ or EURK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MYNZ vs. The Competition

Mainz Biomed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools